Interobserver agreement for detection of malignant features of IPMNs

Interobserver agreement for detection of malignant features of IPMNs - Interobserver agreement for detection of malignant features of IPMNs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038565

Enrollment

Registered

2020-04-01

Start date

2020-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraductal Papillary Mucinous Neoplasms (IPMN)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients were selected who met a CT with multiphasic pancreatic protocol.

Exclusion criteria

Exclusion criteria: Our exclusion criteria were as follows:emergency case, history of an adverse reaction to iodinated contrast media, and proved or suspected pregnancy.

Design outcomes

Primary

Measure	Time frame
Interobserver agreement of lesion features malignant imaging features of IPMN.	—

Countries

Japan

Contacts

Public ContactAkio Tamura

Iwate Medical University Depertment of Radiology

a.akahane@gmail.com0196515111

Outcome results